235 related articles for article (PubMed ID: 18088462)
21. Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562.
Jakubowska J; Stasiak M; Szulawska A; Bednarek A; Czyz M
Acta Biochim Pol; 2007; 54(4):839-46. PubMed ID: 17957275
[TBL] [Abstract][Full Text] [Related]
22. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
Rahmani M; Nguyen TK; Dent P; Grant S
Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
[TBL] [Abstract][Full Text] [Related]
23. Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.
Chen Y; Hu D
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):41-4. PubMed ID: 15165112
[TBL] [Abstract][Full Text] [Related]
24. The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells.
Shen FH; Jin J; Li J; Wang Y; Zhu SH; Lu YJ; Ou TM; Huang ZS; Huang M; Huang ZY
Pharm Biol; 2013 Apr; 51(4):447-54. PubMed ID: 23363047
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of STI571 inducing apoptosis of K562 cells.
Qin Y; Chen S; Chang Y; Fu J; Wang X
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):289-92. PubMed ID: 12411057
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
28. Effects of STI571 and p27 gene clone on proliferation and apoptosis of K562 cells.
Wang W; Yao LB; Liu XP; Feng Q; Shang ZC; Cao YX; Sun BZ
World J Gastroenterol; 2005 Apr; 11(14):2130-5. PubMed ID: 15810079
[TBL] [Abstract][Full Text] [Related]
29. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
Kindler T; Breitenbuecher F; Kasper S; Stevens T; Carius B; Gschaidmeier H; Huber C; Fischer T
Leukemia; 2003 Jun; 17(6):999-1009. PubMed ID: 12764361
[TBL] [Abstract][Full Text] [Related]
30. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
31. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
Jakubowska J; Wasowska-Lukawska M; Czyz M
Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
[TBL] [Abstract][Full Text] [Related]
32. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
33. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
[TBL] [Abstract][Full Text] [Related]
34. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
[TBL] [Abstract][Full Text] [Related]
35. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
[TBL] [Abstract][Full Text] [Related]
36. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
37. Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation.
Dasmahapatra G; Yerram N; Dai Y; Dent P; Grant S
Clin Cancer Res; 2007 Jul; 13(14):4280-90. PubMed ID: 17634558
[TBL] [Abstract][Full Text] [Related]
38. Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571.
Tabrizi R; Mahon FX; Cony Makhoul P; Lagarde V; Lacombe F; Berthaud P; Melo JV; Reiffers J; Belloc F
Leukemia; 2002 Jun; 16(6):1154-9. PubMed ID: 12040447
[TBL] [Abstract][Full Text] [Related]
39. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
Wang Z; Liang R; Huang GS; Piao Y; Zhang YQ; Wang AQ; Dong BX; Feng JL; Yang GR; Guo Y
Apoptosis; 2006 Oct; 11(10):1851-60. PubMed ID: 16850161
[TBL] [Abstract][Full Text] [Related]
40. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].
Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]